Published in J Neurosci Res on March 15, 2005
Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther (2008) 1.94
The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol (2011) 1.38
Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition. Biol Psychiatry (2012) 1.19
Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model. Pharmacol Biochem Behav (2008) 1.14
Opposite effects of early maternal deprivation on neurogenesis in male versus female rats. PLoS One (2009) 1.13
The impact of maternal separation on adult mouse behaviour and on the total neuron number in the mouse hippocampus. Brain Struct Funct (2008) 1.12
Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11
Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun (2015) 1.01
Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. Neuropsychopharmacology (2008) 0.99
Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci (2008) 0.99
Early life manipulations alter learning and memory in rats. Neurosci Biobehav Rev (2012) 0.88
Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience (2011) 0.87
Prenatal nicotine and maternal deprivation stress de-regulate the development of CA1, CA3, and dentate gyrus neurons in hippocampus of infant rats. PLoS One (2013) 0.84
Early life stress differentially modulates distinct forms of brain plasticity in young and adult mice. PLoS One (2012) 0.84
Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology. Front Cell Neurosci (2014) 0.83
Early Life Stress Effects on Glucocorticoid-BDNF Interplay in the Hippocampus. Front Mol Neurosci (2015) 0.80
Maternal separation produces alterations of forebrain brain-derived neurotrophic factor expression in differently aged rats. Front Mol Neurosci (2015) 0.79
The influence of infant-caregiver experiences on amygdala Bdnf, OXTr, and NPY expression in developing and adult male and female rats. Behav Brain Res (2014) 0.79
Early-life stress restricts the capacity of adult progenitor cells to differentiate into neurons. Biol Psychiatry (2015) 0.77
Increased mesohippocampal dopaminergic activity and improved depression-like behaviors in maternally separated rats following repeated fasting/refeeding cycles. J Obes (2012) 0.77
Social buffering in rats: prolactin attenuation of active interaction. Psychol Rep (2008) 0.75
Neuroplastic Correlates in the mPFC Underlying the Impairment of Stress-Coping Ability and Cognitive Flexibility in Adult Rats Exposed to Chronic Mild Stress during Adolescence. Neural Plast (2017) 0.75
Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure. Front Cell Neurosci (2017) 0.75
Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost (2002) 2.16
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol (2002) 2.15
Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand (2002) 1.64
Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. Am J Psychiatry (2009) 1.55
The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia. J Clin Psychiatry (2008) 1.54
Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci (2005) 1.52
Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry (2003) 1.38
The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem (2004) 1.30
Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods (2004) 1.26
Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res (2003) 1.26
Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease. ACS Chem Neurosci (2012) 1.22
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol (2004) 1.16
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci (2010) 1.14
The impact of maternal separation on adult mouse behaviour and on the total neuron number in the mouse hippocampus. Brain Struct Funct (2008) 1.12
Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology (Berl) (2008) 1.12
Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol Aging (2001) 1.12
A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatr Serv (2014) 1.10
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder. Discov Med (2013) 1.10
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol Psychiatry (2006) 1.08
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl Psychiatry (2013) 1.07
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review. Int Clin Psychopharmacol (2014) 1.07
Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology (Berl) (2007) 1.03
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism. J Pharmacol Exp Ther (2010) 1.02
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res (2008) 1.01
Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline. J Neurosci (2011) 0.98
Testing for HIV: concise guidance. Clin Med (2009) 0.98
Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J ECT (2010) 0.96
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol (2005) 0.95
A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat Commun (2013) 0.94
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. Eur J Pharmacol (2004) 0.94
Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J Neurosci Res (2004) 0.93
Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology (Berl) (2008) 0.93
Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy. J Affect Disord (2013) 0.92
Melancholia: restoration in psychiatric classification recommended. Acta Psychiatr Scand (2007) 0.91
Quantitative electroencephalography in OCD patients treated with paroxetine. Clin Electroencephalogr (2003) 0.89
The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol (2002) 0.89
Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice. Psychopharmacology (Berl) (2012) 0.89
Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey. J Med Econ (2010) 0.89
Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor. Eur J Pharmacol (2011) 0.87
Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care Companion J Clin Psychiatry (2010) 0.87
Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr Genet (2010) 0.87
Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials. Appl Health Econ Health Policy (2009) 0.87
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol Dis (2005) 0.86
An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine. Psychopharmacology (Berl) (2012) 0.86
Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. J Biol Chem (2013) 0.85
Aripiprazole versus haloperidol treatment in early-stage schizophrenia. J Psychiatr Res (2010) 0.85
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur J Pharmacol (2003) 0.84
Differential regulation of c-Fos and FosB in the rat brain after amygdala kindling. Cell Mol Neurobiol (2006) 0.83
Increased dopaminergic activity in socially isolated rats: an electrophysiological study. Neurosci Lett (2010) 0.83
Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome. Schizophr Res (2006) 0.83
Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett (2008) 0.83
Dynamic Optical Coherence Tomography in Dermatology. Dermatology (2016) 0.83
Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol Behav (2007) 0.82
Egocentric spatial orientation in a water maze by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull (2005) 0.82
Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: a study of gene-environment interactions. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.82
The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample. Psychiatr Genet (2005) 0.82
Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y. Alcohol Alcohol (2002) 0.81
Socially isolated rats exhibit changes in dopamine homeostasis pertinent to schizophrenia. Int J Dev Neurosci (2010) 0.81
Increased numbers of orexin/hypocretin neurons in a genetic rat depression model. Neuropeptides (2011) 0.81
The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials. Schizophr Res (2008) 0.81
Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective. Prim Care Companion J Clin Psychiatry (2008) 0.81
Somnolence effects of antipsychotic medications and the risk of unintentional injury. Pharmacoepidemiol Drug Saf (2008) 0.81
Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats. Behav Brain Res (2005) 0.80
Electroconvulsive stimulation, but not chronic restraint stress, causes structural alterations in adult rat hippocampus--a stereological study. Hippocampus (2014) 0.79
Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice. Synapse (2014) 0.79
Cognitive deficits in obsessive-compulsive disorder on tests of frontal lobe functions. Nord J Psychiatry (2005) 0.79
Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine. Neuroreport (2009) 0.79
Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol (2006) 0.79
Associative and nonassociative learning after chronic imipramine in rats. Pharmacol Biochem Behav (2003) 0.79
Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett (2008) 0.79
Predictors of aripiprazole treatment continuation in hospitalized patients. J Clin Psychiatry (2008) 0.79
Place learning and object recognition by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull (2004) 0.78
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data. J Child Adolesc Psychopharmacol (2010) 0.78
Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection. J ECT (2014) 0.78
Involvement of Y(5) receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test. Brain Res (2007) 0.78
Addiction-related effects of DOV 216,303 and cocaine: A comparative study in the mouse. Basic Clin Pharmacol Toxicol (2014) 0.78
Place learning in scopolamine-treated rats: the roles of distal cues and catecholaminergic mediation. Neurobiol Learn Mem (2002) 0.78
Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients. Manag Care (2010) 0.78
The effect of subchronic fluoxetine treatment on learning and memory in adolescent rats. Behav Brain Res (2011) 0.78
Novel directions in antipsychotic target identification using gene arrays. Curr Drug Targets CNS Neurol Disord (2002) 0.78
Chronic restraint stress in rats causes sustained increase in urinary corticosterone excretion without affecting cerebral or systemic oxidatively generated DNA/RNA damage. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.78
Pharmacological characterization of social isolation-induced hyperactivity. Psychopharmacology (Berl) (2010) 0.78
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). J Pharmacol Exp Ther (2002) 0.77
[Electroconvulsive therapy in Denmark 1999. A nation-wide questionnaire study]. Ugeskr Laeger (2002) 0.77
Electroconvulsive stimulations prevent chronic stress-induced increases in L-type calcium channel mRNAs in the hippocampus and basolateral amygdala. Neurosci Lett (2012) 0.77
Serotonin, locomotion, exploration, and place recall in the rat. Pharmacol Biochem Behav (2003) 0.76
Maternal separation affects male rat copulatory behaviour and hypothalamic corticotropin releasing factor in concert. Behav Brain Res (2004) 0.76
Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference. Pharmacol Biochem Behav (2013) 0.76
Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade. Neuropeptides (2002) 0.76
Gene-environment interaction affects substance P and neurokinin A in the entorhinal cortex and periaqueductal grey in a genetic animal model of depression: implications for the pathophysiology of depression. Int J Neuropsychopharmacol (2007) 0.76
[Recovery of somatic functions in suicide patient--what about the mental functions?]. Ugeskr Laeger (2009) 0.75
First-line use of ECT. J ECT (2005) 0.75
Should psychiatry become social neuroscience? Acta Neuropsychiatr (2015) 0.75